6467 TWO Week ended 14 Aug 2026

Weekly Investor Report

TAHO Pharma · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 125.0 TWD
10.1% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 1.1% above the Trend Line and sits at 28.9% of its 52-week range. The latest completed week returned 10.1%, after a 10.1% four-week move.

Setup score 33 out of 100
Latest Close 125.0 TWD 14 Aug 2026
1W Return 10.1% latest completed week
4W Return 10.1% short-term follow-through
12W Return -8.4% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 10.1% Latest completed week; four-week move 10.1%. Indicator stack 21/41 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 1.1% above the Trend Line and sits at 28.9% of its 52-week range. The latest completed week returned 10.1%, after a 10.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0512-week average 0.10

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 10.1% over four weeks, -8.4% over 12 weeks, and 35.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W10.1%
4W10.1%
12W-8.4%
26W-2.3%
52W35.1%
Active trend streak0 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.58Latest activity-pressure read.
Pressure change15.2%Four-week change in activity pressure.
Leadership-37.67Latest relative-leadership reading.
RS change5.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment-

No current sentiment snapshot is stored.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-40.0%Distance below the 52-week high.
13-week volatility7.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+12.2%Week of 8 May.
Worst week-17.2%Week of 26 Jun.
Latest week+10.1%Week of 14 Aug.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses6
Sharp losses7
Recent vol7.8%13-week weekly-return volatility.
Base vol11.4%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew9.4% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis13/100

Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.

Activity pressure 0.05; No reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

No sentiment snapshot is stored yet.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
14 Aug 2026125.0 TWD10.1%123.6 TWD62.93 TWD-0.58-37.671.5MOff
7 Aug 2026113.5 TWD2.7%123.2 TWD62.20 TWD-0.72-41.66680.4KOff
31 Jul 2026110.5 TWD7.3%123.4 TWD61.54 TWD-0.68-41.911.4MOff
24 Jul 2026103.0 TWD-9.3%123.6 TWD60.89 TWD-0.77-46.581.3MOff
17 Jul 2026113.5 TWD-1.3%124.5 TWD60.30 TWD-0.69-39.771.0MOff
10 Jul 2026115.0 TWD9.0%125.8 TWD59.64 TWD-0.53-42.44616.8KOff
3 Jul 2026105.5 TWD-2.3%127.3 TWD58.97 TWD-0.51-48.731.4MOff
26 Jun 2026108.0 TWD-17.2%129.5 TWD58.35 TWD-0.36-44.951.8MOff
19 Jun 2026130.5 TWD8.8%131.7 TWD57.71 TWD-0.15-36.23965.0KOff
12 Jun 2026120.0 TWD-2.0%132.9 TWD56.93 TWD-0.06-38.29545.8KOff
5 Jun 2026122.5 TWD-3.5%134.9 TWD56.21 TWD0.35-38.27655.2KOff
29 May 2026127.0 TWD-7.0%136.1 TWD55.47 TWD0.57-35.461.3MOff
22 May 2026136.5 TWD-4.2%137.4 TWD54.71 TWD0.34-26.55891.8KOff
15 May 2026142.5 TWD6.7%138.2 TWD53.89 TWD0.10-21.122.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context